Patents by Inventor Randy L Webb

Randy L Webb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
    Patent number: 9023894
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: May 5, 2015
    Assignee: Novartis AG
    Inventors: William Hewitt, Daniel L Vasella, Randy L Webb
  • Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
    Patent number: 9023893
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: May 5, 2015
    Assignee: Novartis AG
    Inventors: William Hewitt, Daniel L Vasella, Randy L Webb
  • Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
    Patent number: 8618174
    Abstract: The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: December 31, 2013
    Assignee: Novartis AG
    Inventors: William Hewitt, Daniel L Vasella, Randy L Webb
  • Methods of treatment and pharmaceutical composition
    Patent number: 8404744
    Abstract: The invention relates a pharmaceutical composition comprising a combination of (i) the AT 1-antagonist valsartan or a pharmaceutically acceptable salt thereof and (ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of selected conditions or diseases.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: March 26, 2013
    Assignee: Novartis AG
    Inventors: Gary M Ksander, Randy L Webb
  • Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
    Patent number: 8183295
    Abstract: The invention relates to a pharmaceutical composition comprising (i) a renin inhibitor, (ii) a calcium channel blocker (CCB), and a diuretic and to a method of using such composition for the treatment of cardiovascular disease.
    Type: Grant
    Filed: August 8, 2008
    Date of Patent: May 22, 2012
    Assignee: Novartis Pharmaceuticals Corporation
    Inventors: David L Feldman, Randy L Webb
  • Methods of treatment and pharmaceutical composition
    Patent number: 8101659
    Abstract: The invention relates a pharmaceutical composition comprising a combination of: (i) the AT 1-antagonist valsartan or a pharmaceutically acceptable salt thereof; and (ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or disease selected from the group consisting of hypertension, heart failure, such as (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, atherosclerosis, angina (whether unstable or stable), renal insufficiency (diabetic and non-diabetic), heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis, scler
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: January 24, 2012
    Assignee: Novartis AG
    Inventors: Gary M Ksander, Randy L Webb
  • Pharmaceutical composition containing anti-hypertensive agents
    Patent number: 8101599
    Abstract: The present invention relates to a combination of organic compounds, a pharmaceutical composition and a kit of parts comprising said combination of organic compounds and to a method of treatment or prevention of certain conditions or diseases.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: January 24, 2012
    Assignee: Novartis AG
    Inventors: Suraj S Shetty, Randy L Webb
  • THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILAT
    Publication number: 20080287412
    Abstract: The present invention especially relates to the use of a combination comprising (1) an ACEI selected from the group consisting of benazepril, benazeprilat, and pharmaceutically acceptable salts thereof, and (2) amlodipine or pharmaceutically acceptable salt thereof, for the manufacture a medicament for the treatment or prevention or delay of progression of a condition selected from the group consisting of hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular disease, stroke, pulmonary disease or pulmonary hypertension and headache; wherein (i) the amount of amlodipine or a pharmaceutically acceptable salt thereof corresponds to 6 about mg to 40 about mg of the free base and (ii) the amount of the ACE inhibitor or a pharmaceutically thereof corresponds to 20 about mg to 160 about mg o
    Type: Application
    Filed: July 28, 2008
    Publication date: November 20, 2008
    Inventors: Ann R. Comfort, William L. Daley, Santo J. Fleres, Alan E. Royce, Randy L. Webb, William S. Wei